Levothroid — Class II drug recall D-079-2013
Terminated recall by Lloyd Inc. of Iowa, reported 2012-12-12, distributed nationwide. cGMP Deviations; does not meet in process specification requirements
| Recall number | D-079-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lloyd Inc. of Iowa, Shenandoah, IA, United States |
| Recall initiated | 2012-07-09 |
| Classified | 2012-12-03 |
| Reported by FDA | 2012-12-12 |
| Terminated | 2013-11-14 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp |
| NDC | 00456-1330-01 |
| Lot numbers | 1092299, 1096371, 5/312013 |
| Expiration dates | 2013-01-31 |
Product
Levothroid (levothyroxine sodium tablets, USP), 112 mcg., 100-count bottles, Rx only, NDC 0456-1330-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Reason for recall
cGMP Deviations; does not meet in process specification requirements
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-079-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.